Workboat Indexes
Headline News about Axsome Thera
![](https://g.foolcdn.com/editorial/images/770146/stock-chart-on-tablet-young-woman.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
What Analysts Are Saying About Axsome Therapeutics Stock
March 19, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
What Analysts Are Saying About Axsome Therapeutics Stock
February 27, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule.jpg)
![](https://g.foolcdn.com/editorial/images/766287/doctor-with-patient-talking.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
Axsome Therapeutics (AXSM) Q4 2023 Earnings Call Transcript
February 20, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Axsome Therapeutics
February 19, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings For Axsome Therapeutics
February 06, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
The Analyst Landscape: 6 Takes On Axsome Therapeutics
January 16, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Axsome Therapeutics's Future
November 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/brain-3168269-1920.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/02/Stock-AxsomeTherapeutics-02-adobe.jpg)
![](https://g.foolcdn.com/editorial/images/763399/person-working-on-a-laptop.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/AXSM_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/26/jim_cramer_nyse_shutter.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/AXSM.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://g.foolcdn.com/editorial/images/759497/investor-pointing-at-a-chart.jpg)
![](https://g.foolcdn.com/editorial/images/758457/patient-talking-with-a-physician.jpg)
![](https://g.foolcdn.com/editorial/images/759462/cheering-person-with-laptop.jpg)
![](https://g.foolcdn.com/editorial/images/757538/two-people-with-ipad-and-laptop.jpg)
![](https://g.foolcdn.com/editorial/images/755778/gettyimages-667652037.jpg)
![](https://g.foolcdn.com/editorial/images/754554/person-smiling-and-looking-at-laptop.jpg)
![](https://g.foolcdn.com/editorial/images/753859/doctor-standing-in-a-hospital.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/06/axsm.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
Axsome Therapeutics (AXSM) Q3 2023 Earnings Call Transcript
November 06, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://investorplace.com/wp-content/uploads/2022/12/money-printing.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.